Characteristics of 25 patients at diagnosis
| Characteristic . | No. (%) . | Median MVD (range) . |
|---|---|---|
| Sex | ||
| Male | 17 (68) | — |
| Female | 8 (32) | — |
| Location of plasmacytoma | ||
| Spine | 14 (56) | — |
| Long bone | 6 (24) | — |
| Other | 5 (20) | — |
| Monoclonal protein | ||
| Serum | 17 (68) | — |
| Urine monoclonal light chain alone | 2 (8) | — |
| None | 6 (24) | — |
| Angiogenesis | ||
| All | 25 (100) | 26 (2-50) |
| High grade, visual | 16 (64) | 30 (20-50) |
| Low grade, visual | 9 (36) | 11 (2-16) |
| Secretory status* | ||
| Nonsecretory | 6 (24) | 29 (2-50) |
| M protein disappeared with treatment | 7 (28) | 16 (9-32) |
| M protein persistent after treatment | 10 (40) | 26 (3-32) |
| Characteristic . | No. (%) . | Median MVD (range) . |
|---|---|---|
| Sex | ||
| Male | 17 (68) | — |
| Female | 8 (32) | — |
| Location of plasmacytoma | ||
| Spine | 14 (56) | — |
| Long bone | 6 (24) | — |
| Other | 5 (20) | — |
| Monoclonal protein | ||
| Serum | 17 (68) | — |
| Urine monoclonal light chain alone | 2 (8) | — |
| None | 6 (24) | — |
| Angiogenesis | ||
| All | 25 (100) | 26 (2-50) |
| High grade, visual | 16 (64) | 30 (20-50) |
| Low grade, visual | 9 (36) | 11 (2-16) |
| Secretory status* | ||
| Nonsecretory | 6 (24) | 29 (2-50) |
| M protein disappeared with treatment | 7 (28) | 16 (9-32) |
| M protein persistent after treatment | 10 (40) | 26 (3-32) |
— indicates not applicable.
Two patients did not have follow-up M protein available.